Hepatitis

  • Most Topular Stories

  • Have Hepatitis? Start Living Better Now!

    About.com Hepatitis: What's Hot Now
    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    Right now is the best time to start living better and improving your health. If you have hepatitis, there are several things you can do to help improve the health of your liver and help your treatment be more effective. Here are eight helpful ideas to start living better today.
  • Prevalence of Hepatitis B and C Viruses Among Asylum Seekers in Izmir

    MedWorm: Hepatitis B
    24 Jan 2015 | 10:03 pm
    Abstract Hepatitis B and C virus infections are known to be an important health problem all over the World. According to the data from World Health Organization, 350 million people are estimated to have been chronically infected by hepatitis B virus and 180 million people have been infected by hepatitis C virus. Most of the patients are not aware of their illnesses. Hepatitis B and C virus infections are the most common cause of sequel liver disease related to decompensate liver cirrhosis and hepatocellular carcinoma. Many people are obliged to leave their country due to political, economic…
  • Alma restaurant at centre of Hepatitis A scare now closed - 570 News

    hepatitis - Google News
    26 Jan 2015 | 8:23 am
    CTV NewsAlma restaurant at centre of Hepatitis A scare now closed570 NewsA restaurant at the centre of a Hepatitis A scare in Alma has closed its doors. Wellington-Dufferin-Guelph Public Health are continuing to vaccinate patrons after it came to light a food handler at Marj's Village Kitchen had tested positive for the And so it goes: Marj's closes following hepatitis A exposure eventBarfblog (blog)Owner issues statement on Marj's closureCTV Newsall 4 news articles »
  • Can I Donate Blood if I Have Hepatitis?

    About.com Hepatitis: Most Popular Articles
    26 Jan 2015 | 4:31 am
    If you had any kind of viral hepatitis, or unexplained jaundice, at any time since you were age 11, you're not able to donate blood.
  • Are Treatments for HCV Being Over-Promoted?

    Hepatitis Central
    The Editors at Hepatitis Central
    26 Jan 2015 | 9:44 am
    Overdoing Hepatitis C Screenings May Be Bad for your Health By Dianne Depra, Tech Times | January 15 The Centers for Disease Control and Prevention (CDC) in 2012 recommended hepatitis C screenings for anyone born from 1945 to 1965. In 2014, the World Health Organization made the same recommendation, but a group of scientists are not convinced that mass screenings for the age group are effective or even necessary. In a piece published in the journal BMJ, Ronald Koretz, Kenneth Lin, John Ioannidis and Jeanne Lenzer questioned the recommended screening for hepatitis C, concerned that it has no…
  • add this feed to my.Alltop

    MedWorm: Hepatitis B

  • Prevalence of Hepatitis B and C Viruses Among Asylum Seekers in Izmir

    24 Jan 2015 | 10:03 pm
    Abstract Hepatitis B and C virus infections are known to be an important health problem all over the World. According to the data from World Health Organization, 350 million people are estimated to have been chronically infected by hepatitis B virus and 180 million people have been infected by hepatitis C virus. Most of the patients are not aware of their illnesses. Hepatitis B and C virus infections are the most common cause of sequel liver disease related to decompensate liver cirrhosis and hepatocellular carcinoma. Many people are obliged to leave their country due to political, economic…
  • Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans via Serial Community Serologic Testing

    24 Jan 2015 | 10:03 pm
    This study was based on the data collected by testing for Hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibody (HBcAb IgG), anti-HBs antibody (HBsAb), and anti-HCV antibody (anti-HCV) in a series of community screening in VAs in Orange County, California. In 1,405 VA participants, the mean age was 51 (17–87) years, 45.1 % were males; 68.2 %, married; 97.2 %, born in Vietnam. Most of the participants were non-US born with their primary language being non-English and with limited access to health care. Of the 1,405 cases, 124 (8.8 %) were confirmed HBV infection by HBsAg+;…
  • Frequency of Infectious Diseases in Immigrants in a Western European Country: A Population-Based Study

    24 Jan 2015 | 10:03 pm
    Abstract The aim of this population-based study was to assess the incidence rates of infectious diseases in native- (Italian) and foreign-born (immigrants) populations in a North Italy area, in 2006–2010. Crude, age-specific incidence rates (IRs) and age-standardised rate ratios (SRRs) between foreign- and native-born subjects and their 95 % confidence intervals (95 % CI) were estimated. A total of 32,554 cases of infectious diseases were found (9.9 % in foreign-born subjects). The highest SRRs between foreign- and nativeborn subjects were found for tuberculosis (SRR = 27.1; 95 % CI…
  • Characterization of Chronic Hepatitis B Cases Among Foreign-Born Persons in Six Population-Based Surveillance Sites, United States 2001–2010

    24 Jan 2015 | 10:03 pm
    We examined trends by birth country during 2005–2010. Of 36,008 cases, 21,355 (59.3 %) reported birth in a country outside the USA, 2,323 (6.5 %) were US-born. Compared with US-born, foreign-born persons were 9.2 times more frequent among chronic hepatitis B cases. Foreign-born were more frequently female, younger, ever pregnant, and born in China. Percentages of cases among foreign-born persons were constant during 2005–2010. Our findings support information from US surveillance for Hepatitis B screening and vaccination efforts. (Source: Journal of Immigrant and Minority Health)
  • Hepatitis B Awareness and Knowledge in Hepatitis B Surface Antigen-Positive Parturient Immigrant Women from West Africa in the Bronx, New York

    24 Jan 2015 | 10:03 pm
    This study shows that pregnancy-related health interventions may offer unique opportunities to link such women to specialist care and initiate culturally sensitive HBV-relevant education for the index case and her family. (Source: Journal of Immigrant and Minority Health)
 
  • add this feed to my.Alltop

    hepatitis - Google News

  • Alma restaurant at centre of Hepatitis A scare now closed - 570 News

    26 Jan 2015 | 8:23 am
    CTV NewsAlma restaurant at centre of Hepatitis A scare now closed570 NewsA restaurant at the centre of a Hepatitis A scare in Alma has closed its doors. Wellington-Dufferin-Guelph Public Health are continuing to vaccinate patrons after it came to light a food handler at Marj's Village Kitchen had tested positive for the And so it goes: Marj's closes following hepatitis A exposure eventBarfblog (blog)Owner issues statement on Marj's closureCTV Newsall 4 news articles »
  • Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment - Wall Street Journal

    26 Jan 2015 | 2:07 am
    Wall Street JournalGilead to Allow Generic-Drug Makers to Produce New Hepatitis C TreatmentWall Street JournalNEW DELHI— Gilead Sciences Inc. said it would allow generic-drug makers to produce a new version of its Sovaldi hepatitis C treatment. The new drug is currently still undergoing clinical trials, but Gilead believes the new version will be more Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include PR Newswire (press release)Gilead Expands Hepatitis C Generic Licensing Agreements to Include Fort Mills TimesGilead expands hepatitis C agreements to include…
  • Hepatitis C: What Therapy this Week? - HCPLive

    24 Jan 2015 | 1:14 pm
    HCPLiveHepatitis C: What Therapy this Week?HCPLive“We really have entered this new era of direct acting antivirals, and as of this fall, we've finally laid to rest Interferon in the grave that we've all been wanting to put it in, for more than 2 decades,” opened Jacqueline G. O'Leary, MD, MPH, AGAF
  • Over 50? Get Tested for Hepatitis Now: Top Doctor - Newsmax Health

    23 Jan 2015 | 6:28 am
    Over 50? Get Tested for Hepatitis Now: Top DoctorNewsmax HealthBaby boomers, take note: Three-quarters of all hepatitis C cases in the U.S. are in Americans born between 1945 and 1964. What's more, 75 percent of the boomers who have Hep C don't even know it because it typically has no symptoms and is often missed ...
  • Senators balk at cost of hepatitis C drug, other mid-year expenses - STLtoday.com

    22 Jan 2015 | 3:53 pm
    STLtoday.comSenators balk at cost of hepatitis C drug, other mid-year expensesSTLtoday.comThe Medicaid program is seeking $35 million for increased prescription drug costs this fiscal year. The main cost-driver is Sovaldi, produced by California drugmaker Gilead Sciences and used to treat hepatitis C. The pills cost $87,000 for a 12-week dose.and more »
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • Have Hepatitis? Start Living Better Now!

    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    Right now is the best time to start living better and improving your health. If you have hepatitis, there are several things you can do to help improve the health of your liver and help your treatment be more effective. Here are eight helpful ideas to start living better today.
  • The Mouth

    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    Hepatitis. Page 2.
  • What's the Spleen? Here's an Ex-Spleen-ation

    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    What's the Spleen? The spleen is an organ involved in the production and maintenance of red blood cells, the production of certain circulating white blood cells, as a part of the lymph system, and as a part of the immune system. Page 8.
  • Is Hepatitis B Spread Through Sex?

    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    Learn about how the Hepatitis B virus spreads, how to prevent your infection, and what other ways you can get infected with HBV.
  • What Is Acute Liver Failure?

    hepatitis.guide@about.com
    26 Jan 2015 | 3:13 am
    Acute liver failure is a medical emergency that is rare but can result from various types of hepatitis, especially hepatitis A and hepatitis B infections.
 
  • add this feed to my.Alltop

    Hepatitis Central

  • Are Treatments for HCV Being Over-Promoted?

    The Editors at Hepatitis Central
    26 Jan 2015 | 9:44 am
    Overdoing Hepatitis C Screenings May Be Bad for your Health By Dianne Depra, Tech Times | January 15 The Centers for Disease Control and Prevention (CDC) in 2012 recommended hepatitis C screenings for anyone born from 1945 to 1965. In 2014, the World Health Organization made the same recommendation, but a group of scientists are not convinced that mass screenings for the age group are effective or even necessary. In a piece published in the journal BMJ, Ronald Koretz, Kenneth Lin, John Ioannidis and Jeanne Lenzer questioned the recommended screening for hepatitis C, concerned that it has no…
  • New Hepatitis C Drugs Coming in 2015

    Nicole Cutler L.Ac.
    12 Jan 2015 | 12:38 pm
    The scope of chronic Hepatitis C infection seems to be getting the pharmaceutical attention needed to eventually reduce this infectious disease’s burden. Based on the combinations of drugs currently in clinical development, we expect big advances for Hepatitis C treatment in 2015. Progress seems to be happening rapidly in the Hepatitis C drug treatment arena. Approved by the U.S. Food and Drug Administration (FDA) in 2011, Incivek was a seemingly miraculous new Hepatitis C drug. While it greatly improved the likelihood of beating the Hepatitis C virus in 2011, Incivek has already been…
  • Which Pharmacy Will Exclusively List Gilead on its Hep C Formularies?

    admin
    12 Jan 2015 | 6:47 am
    CVS Pharmacy to Get Hepatitis C Drugs Only from Gilead By Catherine Kolonko | January 09, 2015 The battle over prescription exclusivity of new hepatitis C drugs continued recently when CVS Caremark revealed a new agreement with drug maker Gilead Sciences to list only Harvoni and Sovaldi on its formularies. The revelation comes within weeks after Express Scripts announced it had penned an exclusive agreement with drug maker AbbVie to carryViekira Pak, a hepatitis C drug regimen newly approved by the Food and Drug Administration. The CVS agreement was made after the prescription benefits…
  • Gilead’s Price Battle with Express Scripts

    The Editors at Hepatitis Central
    24 Dec 2014 | 8:46 am
    Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival By Caroline Humer (Reuters) – The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc’s newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc’s treatments after trying for nearly a year to win a deeper discount. Express Scripts’ move reignited investor concerns that pharmaceutical companies will have to bow to pricing pressure from U.S. insurers and lawmakers over novel medications whose cost can reach hundreds of…
  • Breaking News: Viekira Pak Approved for Hep C

    Nicole Cutler L.Ac.
    23 Dec 2014 | 8:06 am
    The race for better Hepatitis C treatments just got closer with the approval of another all-oral drug regimen. The U.S. Food and Drug Administration (FDA) approved AbbVie Inc’s new multi-drug combination on December 19, heightening the competition for Hepatitis C treatment before the end of 2014. As more medications demonstrate a supreme ability to battle Hepatitis C, the standard of care continually improves. On December 19, 2014, Viekira Pak became the fourth drug treatment approved since November 2013 to treat chronic Hepatitis C. The previous three are: Olysio (simeprevir) was FDA…
 
  • add this feed to my.Alltop

    Hepatitis News

  • Impaired uptake of conjugated bile acids and Hepatitis B Virus...

    26 Jan 2015 | 8:11 am
    The Na+-taurocholate cotransporting polypeptide mediates uptake of conjugated bile acids and is localized at the basolateral membrane of hepatocytes. NTCP has recently been recognized as the receptor mediating hepatocyte-specific entry of Hepatitis B and Hepatitis Delta viruses .
  • Eisai and Ajinomoto Pharmaceuticals Launch Branched-Chain Amino Acid...

    26 Jan 2015 | 2:52 am
    Eisai Co., Ltd. and Ajinomoto Pharmaceuticals Co., Ltd. announced today that LIVAMIN Oral Granules , a branched-chain amino acid formula, was launched in the Philippines. Ajinomoto Pharmaceuticals holds the manufacturing and marketing authorization rights to LIVAMIN Oral Granules.
  • Anti-measles campaign in Rawalpindi starts today

    25 Jan 2015 | 6:28 pm
    ISLAMABAD/RAWALPINDI: Two-week long anti-measles campaign will commence from January 26 in district Rawalpindi as the process for setting up teams and providing training to them has been completed. According to the Rawalpindi Executive District Officer Health Dr Khalid Randhawa, as many as 280 male and female patrols in addition to lady health workers and lady health visitors will be assigned the duties during this campaign in the district Rawalpindi.
  • Market Report, "NanoViricides, Inc. (NNVC) - Financial and Strategic SWOT Analysis Review", published

    25 Jan 2015 | 2:18 pm
    The company discovers, develops, and commercializes therapeutics for life-threatening viral infections. Its drug candidates include injectable flucide clinical candidate, oral flucide clinical candidate, EKC-cide-I, hivcide-I, rabicide-I, TBD and ADIF-base-I.
  • "Hepatitis C Global Clinical Trials Review, H2, 2014" Published

    25 Jan 2015 | 10:18 am
    This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis…
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Another Hepatitis A Illness Linked to Rosa’s Restaurant

    Bill Marler
    9 Jan 2015 | 5:34 pm
    Another Hepatitis A case is being reported by a person who ate at the same restaurant in Hamilton Township. Robbinsville Township health officials say the resident ate at Rosa’s Restaurant on 3442 South Broad Street during the time when a food handler reported having Hepatitis A. The patient works in Hamilton Township. However, health officials say coworkers at the job only have a negligible risk. The first case of Hepatitis A was confirmed last month in a worker at Rosa’s. In light of that, the township hosted a vaccination clinic at a local firehouse. Then last week health…
  • Hepatitis A Cases Linked in New Jersey Restaurant

    Bill Marler
    2 Jan 2015 | 7:47 am
    On Thursday, health officials in Hamilton, NJ, confirmed two more cases of Hepatitis A in the township about a month after a food service worker at Rosa’s Restaurant and Catering in Hamilton first became infected with the virus. Health officials said that an employee of the Hair Port Salon in Hamilton had been diagnosed with Hepatitis A infection. The employee has been released from the hospital and is recovering at home, they added. Staff and customers who visited the salon between Dec. 4 and Dec. 30 may be at risk of contracting the virus and should be vaccinated if they have not already…
  • Hamilton NJ Misses Hepatitis A Outbreak

    Bill Marler
    30 Dec 2014 | 4:55 am
    More than four weeks after a food service employee at a popular Hamilton restaurant was diagnosed with hepatitis A, no additional cases have emerged and the possible incubation period is nearly over, health officials said Friday. Township health officer Jeff Plunkett said there were a few suspected cases including one false positive test, but none were confirmed following the initial infection of a worker for Rosa’s Restaurant and Catering on South Broad Street. “It was intense there for a period of a week or 10 days, but everybody was extremely cooperative,” Plunkett said…
  • Hamilton New Jersey Rosa’s Restaurant Hepatitis A Scare

    Bill Marler
    1 Dec 2014 | 8:19 pm
    Cristina Rojas reports that a confirmed case of hepatitis A has been traced to a food worker employed at Rosa’s Restaurant and Catering in Hamilton, officials said late Monday. Health officials warned that anyone who ate at or catered from the restaurant between Nov. 10 and Monday may be at risk for developing Hepatitis A if they have not been previously vaccinated. Unvaccinated individuals who ate there should receive an injection of immune globulin or hepatitis A vaccine. Both can prevent an infection if given within 14 days of exposure. Officials urged anyone who ate at the restaurant…
  • Red Robin Restaurant Hepatitis A Exposure Class Action lawsuit – Missouri (2014)

    Bill Marler
    28 Oct 2014 | 5:14 pm
    Springfield Missouri Health officials administered more than 5,000 doses of the hepatitis A vaccine. On May 20, 2014, health department officials learned of a food service worker at the Red Robin restaurant who had tested positive for Hepatitis A. Individuals potentially exposed to the Hepatitis A virus dined at the restaurant between May 8 and 16. Marler Clark filed a class action lawsuit against Red Robin restaurant.  The lawsuit was filed on behalf of restaurant patrons who received hepatitis A vaccinations after alleged exposure to the hepatitis A virus at the restaurant between May 8…
 
  • add this feed to my.Alltop

    HCV New Drug Research

  • Current and Future HCV Therapy-Do We Still Need Other Anti-HCV Drugs?

    26 Jan 2015 | 6:27 am
    Liver InternationalCurrent and Future HCV Therapy-Do We Still Need Other Anti-HCV Drugs?Salvatore Petta, Antonio CraxìLiver International. 2015;35(s1):4-10.Abstract and IntroductionAbstractEradication of hepatitis C virus (HCV) infection, at least in compensated patients, can help improve the outcomes of liver disease such as cirrhosis, hepatocellular carcinoma (HCC) and liver transplantation, as well as perhaps extra-hepatic complications such as diabetes and cardiovascular risk. In the past few years, the landscape of antiviral therapy has evolved at a breathtaking pace from pegylated…
  • Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

    26 Jan 2015 | 5:12 am
    WSJ:Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C TreatmentGilead Sciences Believes New Version Will Be More Effective at Treating Hepatitis CBloomberg:Gilead Expands Generic Sovaldi Pact to Add Investigational Pill Gilead Sciences Inc. (GILD) said it aims to launch Sovaldi, its blockbuster hepatitis C drug, in India by June while expanding the reach of a generic licensing agreement with Indian drugmakers to include an investigational combination pill. The pill, which combines sofosbuvir, the chemical name for Sovaldi, with GS-5816, a compound in advanced clinical…
  • HCV Weekend Video - Basic facts on hepatitis C

    25 Jan 2015 | 11:05 am
    Hepatitis C Uploaded by Gastrointestinal SocietyPublished on Jan 20, 2015Hepatitis C is a liver disease caused by the Hepatitis C virus, this video discusses screening, symptoms, treatments, and more about this curable disease.For more free information on this and other digestive diseases and disorders the Society covers, please visit our website http://www.badgut.org/Chronic Hepatitis CUploaded by RajmufPublished on Jan 17, 2015References:http://www.hcvguidelines.org/http://www.jabfm.com/content/27/2/284...Detailed Overview: Transmission, testing, management, and new…
  • Sofosbuvir-based regimens for HCV: SVR12 Is Equivalent to SVR24 in Assessing New HCV Regimens

    25 Jan 2015 | 9:11 am
    Related Video Podcast: Jan 16 2015AASLD Video Podcast: Concordance of Sustained Virological Response With Sofosbuvir-containing Regimens for HCVFull text available; Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus NEJM Journal Watch January 23, 2015SVR12 Is Equivalent to SVR24 in Assessing New HCV RegimensAtif Zaman, MD, MPH reviewing Yoshida EM et al. Hepatology 2015 Jan.The two efficacy endpoints were highly concordant in data from phase III trials of sofosbuvir-based…
  • German insurers win discounts on Gilead's Sovaldi

    24 Jan 2015 | 2:30 pm
    German insurers win discounts on Gilead's SovaldiFRANKFURT (Reuters) - U.S. biotechnology company Gilead (GILD.O) has conceded its first discounts in Germany on its key hepatitis C drugs Sovaldi and Harvoni, German business weekly WirtschaftsWoche reported.The head of Gilead's German operations told the magazine that discounts from the list price of 60,000 euros (44,867 pounds) per treatment had been negotiated with four of Germany's statutory health insurers but declined to give the size of the discounts."Thirty-five percent of people with statutory health insurance are already profiting…
Log in